A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
The purposes of this study are to determine:
It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate LY900003 plus gemcitabine and cisplatin for other possible uses or for other medical or scientific purposes other than those currently proposed.
LY900003 may not add any benefit to gemcitabine plus cisplatin.
Inclusion Criteria:
Exclusion Criteria:
Ciudad de Buenos Aires, Argentina
Grobhansdorf, Germany
Koin, Germany
Neustadt/Suedharz, Germany
New Dehli, India
Nieuwegien, Netherlands
Krakow-Nowa Huta, Poland
Parklands, South Africa
Tygerberg, South Africa
Stockhlom, Sweden